- $1.12bn
- $1.89bn
- $924.22m
- 68
- 72
- 12
- 50
Annual balance sheet for Neogen, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 344 | 381 | 381 | 246 | 171 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 84.7 | 91.8 | 99.7 | 153 | 173 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 537 | 591 | 627 | 586 | 589 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 80.6 | 103 | 114 | 211 | 292 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 797 | 920 | 993 | 4,554 | 4,549 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 48.5 | 53.6 | 77.8 | 145 | 154 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 72 | 79.8 | 106 | 1,420 | 1,405 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 725 | 840 | 887 | 3,134 | 3,144 |
Total Liabilities & Shareholders' Equity | 797 | 920 | 993 | 4,554 | 4,549 |
Total Common Shares Outstanding |